RM

Rashminkumar Manaharbhai Gondaliya

Active Director Managing Director DIN 11928432
DIN 11928432 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rashminkumar Manaharbhai Gondaliya

Rashminkumar Manaharbhai Gondaliya is a Managing Director at Zexa Meditech Private Limited (since 2026).

DIN 11928432
Primary Designation Managing Director
First Appointment 05 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zexa Meditech Private Limited U32506GJ2026PTC183261
Managing Director05 Sep 20262026Active

Board colleagues of Rashminkumar Manaharbhai Gondaliya

NameDINCompanyDesignation
Shyam Chimanbhai Baldha11928431Zexa Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zexa Meditech Private Limited
Premium access

Shareholding and investment profile for Rashminkumar Manaharbhai Gondaliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashminkumar Manaharbhai Gondaliya

Rashminkumar Manaharbhai Gondaliya currently holds 1 directorship: Zexa Meditech Private Limited (Managing Director, since 05 Sep 2026).

Rashminkumar Manaharbhai Gondaliya was first appointed on 05 Sep 2026 as Managing Director at Zexa Meditech Private Limited.

The current boards of Rashminkumar Manaharbhai Gondaliya's companies include Shyam Chimanbhai Baldha (Zexa Meditech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available